Virax Biolabs Group Limited Ordinary Shares
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2023-09-30 |
|---|---|---|---|
Revenue | $4 | $79 | $76 |
Gross Profit | -6 | 40 | 10 |
EBITDA | -2,766 | -3,722 | -2,688 |
EBIT | -2,878 | -3,808 | -2,706 |
Net Income | -2,756 | -3,823 | -2,909 |
Net Change In Cash | 4 | 79 | 76 |
Free Cash Flow | -2,166 | -3,249 | -4,165 |
Cash | 7,285 | 3,589 | 5,107 |
Basic Shares | 3,103 | 2,237 | 1,775 |
Annual Financials
| Values in thousands | 2024-03-31 | 2023-03-31 | 2022-03-31 | 2021-03-31 |
|---|---|---|---|---|
Revenue | $156 | $8 | $0 | $123 |
Gross Profit | 50 | -1 | 0 | -9 |
EBITDA | -6,609 | -5,442 | -644 | |
EBIT | -6,712 | -5,442 | -1,734 | -1,289 |
Net Income | -6,733 | -5,457 | -1,708 | -650 |
Net Change In Cash | 156 | 8 | 0 | 123 |
Free Cash Flow | -7,411 | -4,358 | -809 | -590 |
Cash | 3,589 | 9,352 | 21 | 17 |
Basic Shares | 2,006 | 1,062 | 1,137 | 1,137 |
Earnings Calls
| Quarter | EPS |
|---|---|
2022-06-30 | -$0.03 |
